Literature DB >> 19568768

Differences in the expression of histamine-related genes and proteins in normal human adrenal cortex and adrenocortical tumors.

Peter M Szabó1, Zoltán Wiener, Zsófia Tömböl, Attila Kovács, Péter Pócza, János Horányi, Janina Kulka, Peter Riesz, Miklós Tóth, Attila Patócs, Rolf C Gaillard, András Falus, Károly Rácz, Peter Igaz.   

Abstract

Histamine is involved in the pathogenesis of several tumors; however, there are no data on its possible involvement in human adrenocortical tumorigenesis. The expression of genes and proteins involved in the biosynthesis (histidine decarboxylase, HDC), action (histamine receptors: HRH1-HRH4), and metabolism of histamine is largely unknown both in the normal human adrenal cortex and in adrenocortical tumors. In this study, we examined the expression of histamine-related genes and proteins and histamine content in normal adrenal cortex, benign adrenocortical adenomas, and malignant adrenocortical cancer (ACC). Fifteen normal adrenals and 43 tumors were studied. mRNA expression was examined by real time RT-PCR. Western-blotting and immunohistochemistry were used for the study of proteins. Tissue histamine content was determined by enzyme-linked immunosorbent assay. We found that all proteins involved in histamine biosynthesis and action are present both in the normal adrenal cortex and in the tumors studied. HDC expression and histamine content was highest in the normal tissues and lower in benign tumors, whereas it was significantly less in ACCs. HRH3 expression was significantly higher in ACC samples than in the other groups. Adrenocortical tumorigenesis might, thus, be characterized by reduced histamine biosynthesis; furthermore, different adrenocortical tumor subtypes may show unique histamine receptor expression profiles.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19568768     DOI: 10.1007/s00428-009-0807-x

Source DB:  PubMed          Journal:  Virchows Arch        ISSN: 0945-6317            Impact factor:   4.064


  45 in total

1.  Histamine-induced increases in cyclic AMP levels in bovine adrenal medullary cells.

Authors:  P D Marley; K A Thomson; K Jachno; M J Johnston
Journal:  Br J Pharmacol       Date:  1991-12       Impact factor: 8.739

Review 2.  Systemic mast cell disease (mastocytosis). General aspects and histopathological diagnosis.

Authors:  H P Horny; P Ruck; S Kröber; E Kaiserling
Journal:  Histol Histopathol       Date:  1997-10       Impact factor: 2.303

3.  Localization of the histamine H(2) receptor, a target for antiulcer drugs, in gastric parietal cells.

Authors:  Y Fukushima; Y Ohmachi; T Asano; M Nawano; M Funaki; M Anai; T Ogihara; K Inukai; Y Onishi; H Sakoda; T Saitoh; N Matsuhashi; Y Yazaki; K Sugano
Journal:  Digestion       Date:  1999 Nov-Dec       Impact factor: 3.216

Review 4.  The histamine H4 receptor as a new therapeutic target for inflammation.

Authors:  Iwan J P de Esch; Robin L Thurmond; Aldo Jongejan; Rob Leurs
Journal:  Trends Pharmacol Sci       Date:  2005-09       Impact factor: 14.819

5.  Histamine-immunoreactive endocrine cells in the adrenal medulla of the rat.

Authors:  O Häppölä; S Soinila; H Päivärinta; T H Joh; P Panula
Journal:  Brain Res       Date:  1985-07-29       Impact factor: 3.252

Review 6.  The c-kit receptor, stem cell factor, and mast cells. What each is teaching us about the others.

Authors:  S J Galli; M Tsai; B K Wershil
Journal:  Am J Pathol       Date:  1993-04       Impact factor: 4.307

7.  The relationship between adrenal vascular events and steroid secretion: the role of mast cells and endothelin.

Authors:  J P Hinson; G P Vinson; S Kapas; R Teja
Journal:  J Steroid Biochem Mol Biol       Date:  1991       Impact factor: 4.292

Review 8.  Adrenocortical cancer: pathophysiology and clinical management.

Authors:  Rossella Libè; Amato Fratticci; Jérôme Bertherat
Journal:  Endocr Relat Cancer       Date:  2007-03       Impact factor: 5.678

9.  Numerous mast cells in an 11-deoxycorticosterone-producing adrenocortical tumor. Histologic evaluation of benignancy and comparison with mast cell distribution in adrenal glands and neoplastic counterparts of 67 surgical specimens.

Authors:  M Aiba; H Iri; H Suzuki; K Kageyama; T Kawai; O Abe; M Murai; H Tazaki; T Saruta
Journal:  Arch Pathol Lab Med       Date:  1985-04       Impact factor: 5.534

10.  Diamine-oxidase activity and tissue di- and poly-amine contents of human ovarian, cervical and endometrial carcinoma.

Authors:  R Chanda; A K Ganguly
Journal:  Cancer Lett       Date:  1995-02-10       Impact factor: 8.679

View more
  1 in total

1.  Inhibition of histamine receptor 3 suppresses glioblastoma tumor growth, invasion, and epithelial-to-mesenchymal transition.

Authors:  Jia-Ji Lin; Tian-Zhi Zhao; Wen-Ke Cai; Yong-Xiang Yang; Chao Sun; Zhuo Zhang; Yu-Qiao Xu; Ting Chang; Zhu-Yi Li
Journal:  Oncotarget       Date:  2015-07-10
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.